or Try an Advanced Search...

    Technical Analysis for NSPR - InspireMD, Inc.

    Grade Last Price % Change Price Change
    D 2.48 0.01% 0.00
    NSPR closed up 0.01 percent on Friday, November 1, 2024, on 3.87 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Nov 4
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Flat
    Historical NSPR trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    200 DMA Resistance Bearish 0.00%
    Shooting Star Candlestick Bearish 0.00%
    Lizard Bearish Bearish Day Trade Setup 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Doji - Bearish? Reversal 0.00%
    Outside Day Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    20 DMA Resistance Bearish 0.01%
    Older End-of-Day Signals for NSPR ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 19 hours ago
    Rose Above Previous Day's High about 19 hours ago
    20 DMA Resistance about 19 hours ago
    2x Volume Pace about 19 hours ago
    1.5x Volume Pace about 19 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NSPR Chart by TradingView
    Basic chart:

    Profile

    InspireMD Inc., a medical device company, focuses on the development and commercialization of proprietary MGuard stent platform technology. Its lead products include MGuard stent, an embolic protection device based on a protective sleeve, which is constructed out of an ultra-thin polymer mesh and wrapped around the stent; and MGuard Prime, which include its mesh sleeve wrapped around a cobalt-chromium stent. The company markets its products for use primarily in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack), and saphenous vein graft coronary interventions (bypass surgery). It sells its products through distributors in Europe, southeast Asia, India, and Latin America. InspireMD Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Medicine Medical Device Interventional Radiology Cobalt Platform Technology Syndromes Veins Bypass Circulatory System Heart Attack Interventional Cardiology Stent Bypass Surgery Embolic Protection Device Infarction Myocardial Infarction Percutaneous Coronary Intervention

    Is NSPR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 21 One InspireMD Insider Raised Stake By 13% In Previous Year
    Oct 15 InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System
    Oct 8 InspireMD Advances with FDA Study Approval and Global Goals
    Oct 7 InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System
    Sep 16 InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System
    Sep 14 Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 88% over the last five years
    Aug 9 InspireMD, Inc. (NSPR) Q2 2024 Earnings Call Transcript
    Aug 7 Companies Like InspireMD (NASDAQ:NSPR) Are In A Position To Invest In Growth
    Aug 6 InspireMD GAAP EPS of -$0.22, revenue of $1.74M
    Aug 6 InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update
    See more NSPR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.4788
    52 Week Low 1.81
    Average Volume 17,724
    200-Day Moving Average 2.57
    50-Day Moving Average 2.65
    20-Day Moving Average 2.53
    10-Day Moving Average 2.47
    Average True Range 0.12
    RSI (14) 40.12
    ADX 24.39
    +DI 19.49
    -DI 7.65
    Chandelier Exit (Long, 3 ATRs) 2.40
    Chandelier Exit (Short, 3 ATRs) 2.80
    Upper Bollinger Bands 2.70
    Lower Bollinger Band 2.36
    Percent B (%b) 0.35
    BandWidth 13.47
    MACD Line -0.06
    MACD Signal Line -0.06
    MACD Histogram 0.0036
    Fundamentals Value
    Market Cap 53.44 Million
    Num Shares 21.5 Million
    EPS -1.29
    Price-to-Earnings (P/E) Ratio -1.92
    Price-to-Sales 10.83
    Price-to-Book 1.38
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.72
    Resistance 3 (R3) 2.74 2.68 2.68
    Resistance 2 (R2) 2.68 2.62 2.67 2.67
    Resistance 1 (R1) 2.58 2.58 2.56 2.56 2.65
    Pivot Point 2.52 2.52 2.51 2.51 2.52
    Support 1 (S1) 2.42 2.46 2.40 2.40 2.31
    Support 2 (S2) 2.36 2.42 2.35 2.29
    Support 3 (S3) 2.26 2.36 2.28
    Support 4 (S4) 2.24